Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control
- 25 September 2022
- journal article
- editorial
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 7 (3) , 163-167
Abstract
Gastrointestinal involvement is a common complication in systemic sclerosis patients and must be suspected and investigated already in the early stages of the disease. Gastrointestinal symptoms and complications—such as gastroesophageal reflux disease, intestinal pseudo-obstruction, malnutrition, diarrhea, constipation, and small intestinal bacterial overgrowth—severely impair systemic sclerosis patients’ quality of life and affect their prognosis. Although some pathogenetic aspects of the gastrointestinal involvement in systemic sclerosis remain unclear, defining the characteristics of the microbiota and its role could help in risk stratification, selection of candidates for microbiota-targeted therapies, prediction of standard treatment efficacy, and prognosis of systemic sclerosis patients. Finally, understanding how to modify the microbiota composition may represent an important therapeutic approach to target gastrointestinal involvement in systemic sclerosis.Keywords
This publication has 26 references indexed in Scilit:
- Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIGAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2016
- The interplay between the microbiome and the adaptive immune response in cancer developmentTherapeutic Advances in Gastroenterology, 2016
- Brief Report: Intestinal Dysbiosis in Ankylosing SpondylitisArthritis & Rheumatology, 2014
- Intestinal Dysbiosis Associated with Systemic Lupus ErythematosusmBio, 2014
- The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseCell Host & Microbe, 2014
- Measuring response in the gastrointestinal tract in systemic sclerosisCurrent Opinion in Rheumatology, 2013
- Association of gut microbiota with post-operative clinical course in Crohn’s diseaseBMC Gastroenterology, 2013
- Effects of Scleroderma Antibodies and Pooled Human Immunoglobulin on Anal Sphincter and Colonic Smooth Muscle FunctionGastroenterology, 2012
- IBD—what role do Proteobacteria play?Nature Reviews Gastroenterology & Hepatology, 2012
- Microbial Influences in Inflammatory Bowel DiseasesGastroenterology, 2008